The conference was opened by Director General of the Pirogov Center, Corresponding Member of the Russian Academy of Sciences, Professor Oleg Eduardovich Karpov, who noted the importance and necessity of the event, the importance of introducing high-dose immunosuppressive therapy in the treatment of autoimmune diseases, which allows you to fundamentally change the course of the pathological process, and in some cases to save the patient from a serious illness. He also conveyed congratulations from the President of the Pirogov Center, Academician of the Russian Academy of Sciences Yuri Leonidovich Shevchenko and noted the leading role of the Pirogova Center in the study and practical implementation of this problem.
The conference was attended by over 250 specialists in various fields of medicine: hematologists, rheumatologists, neurologists, transplantologists, gastroenterologists, immunologists, biologists, pediatricians, as well as experts from the USA (R. Bert, G. Gorodokin), Great Britain (D. Sowden), Germany (A. Tobias), Sweden (J. Birman), Italy (N. Del Papa, R. Sacardi), Spain (R. Monserat), France (D. Farge), Republic of Belarus (L. Uss), Vietnam ( L.T. Nguyem).
The conference was also attended by specialists from leading medical and educational institutions of Russia (Blokhin Oncology Research Center, Rogachev Institute of Pediatric Oncology, Hematology and Immunology, Almazov Oncology Research Center, and Pirogov Medical University, Burdenko State Military Medical University, St. Petersburg State University, Kirov Military Medical Academy, First St. Petersburg Medical University named after Academician I.P. Pavlov).
A keynote address on the subject of immunology and the pathogenesis of autoimmune diseases was made by the rector of the Russian National Research Medical University named after N.I. Pirogov, academician of the RAS S.A. Lukyanov. Director of the Research Institute of Rheumatology named after V.A. Nasonova, Professor A.M. Leela made a presentation on the general issues of pathology and treatment of systemic diseases of the connective tissue.
The Russian experience, which is the largest in the world (more than 1000 transplantations in autoimmune diseases), was summarized in a report by D.A. Fedorenko, which caused lively discussion and interest of the conference participants.
Professor Ionova T.I. gave a memorial lecture on Andrei Arkadievich Novik, the founder of the high-dose immunosuppressive therapy for autoimmune diseases in Russia.
A joint session of the Association of Patients with Multiple Sclerosis (Russia) and the Society of Patients Multiple Sclerosis (Great Britain) was held as part of the conference.
The participants and guests of the conference noted the high scientific and methodological level of the organization of the event, as well as the need for international cooperation and cooperation of specialists of various medical profiles in studies of the topic of hematopoietic stem cell transplantation in autoimmune diseases.